Nadezhda A. Podoplelova

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Journal: Thrombosis research

Published: February 25, 2026

Unveiling the rationale behind common platelet isolation workflows.

Unveiling the rationale behind common platelet isolation workflows.

Journal: Current opinion in hematology

Published: November 05, 2025

NETosis and Neutrophil Activity Quantification in Pediatric Patients with Essential Thrombocythemia.

NETosis and Neutrophil Activity Quantification in Pediatric Patients with Essential Thrombocythemia.

Journal: International journal of molecular sciences

Published: October 30, 2025

Beyond Direct Fibrinolysis: Novel Approaches to Thrombolysis.

Beyond Direct Fibrinolysis: Novel Approaches to Thrombolysis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 27, 2025

Cytotoxicity and Antiplatelet Activity of Cationic Antimicrobial Peptides of the Medicinal Leech Hirudo Medicinalis.

Cytotoxicity and Antiplatelet Activity of Cationic Antimicrobial Peptides of the Medicinal Leech Hirudo Medicinalis.

Journal: Cell biochemistry and biophysics

Published: July 28, 2025

Design, Synthesis, and In Vitro and In Silico Study of New Hybrid 1-(2-(4-Arylthiazol-2-yl)hydrazineylidene)-5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2-ones as Factor Xa and Factor XIa Inhibitors.

Design, Synthesis, and In Vitro and In Silico Study of New Hybrid 1-(2-(4-Arylthiazol-2-yl)hydrazineylidene)-5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2-ones as Factor Xa and Factor XIa Inhibitors.

Journal: Molecules (Basel, Switzerland)

Published: July 14, 2025

Binding of coagulation factor IXa to procoagulant platelets revisited: Low affinity and interactions with other factors.

Binding of coagulation factor IXa to procoagulant platelets revisited: Low affinity and interactions with other factors.

Journal: Biochemical and biophysical research communications

Published: April 16, 2024

Chemical Adjustment of Fibrinolysis.

Chemical Adjustment of Fibrinolysis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 06, 2023

Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa.

Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa.

Journal: Molecules (Basel, Switzerland)

Published: October 30, 2023

New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation.

New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation.

Journal: Molecules (Basel, Switzerland)

Published: March 21, 2023

Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome.

Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome.

Journal: Orphanet journal of rare diseases

Published: December 29, 2022

Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon.

Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon.

Journal: Blood advances

Published: December 19, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026